Baxter International (BAX) Cash from Operations (2009 - 2026)
Baxter International's (BAX) quarterly Cash from Operations came in at $297.0 million in Q2 2026, down 4.5% year-over-year from $311.0 million in Q2 2025, and up 39.44% quarter-over-quarter from $213.0 million in Q1 2026.
Analysis
Baxter International (BAX) Cash from Operations (2009 - 2026) Analysis & Trends
Baxter International (BAX) has reported Cash from Operations for 18 consecutive years, with $297.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations fell 4.5% year-over-year to $297.0 million in Q2 2026; TTM through Jun 2026 was $1.3 billion, a 56.34% increase from a year earlier, with the FY2025 full-year figure at $951.0 million, down 6.67% from the prior year.
- Cash from Operations was $297.0 million for Q2 2026 at Baxter International, up from $213.0 million in the prior quarter.
- Over five years, Cash from Operations peaked at $596.0 million in Q4 2025 and troughed at -$193.0 million in Q1 2025.
- A 5-year average of $300.9 million and a median of $293.5 million in 2022 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations sank 218.4% in 2025 and surged 210.36% in 2026, its largest moves.
- Over 5 years, Cash from Operations stood at $439.0 million in 2022, then increased by 20.96% to $531.0 million in 2023, then dropped by 8.1% to $488.0 million in 2024, then climbed by 22.13% to $596.0 million in 2025, then tumbled by 50.17% to $297.0 million in 2026.
- The last three Cash from Operations figures came in at $297.0 million (Q2 2026), $213.0 million (Q1 2026), and $596.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 776.00 Mn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 715.00 Mn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 124.00 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 297.00 Mn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 37.08 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 13.12 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 2.11 Mn |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | -1.73 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | -138,013.00 |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 297.00 Mn |
| Mar 31, 2026 | 213.00 Mn |
| Dec 31, 2025 | 596.00 Mn |
| Sep 30, 2025 | 237.00 Mn |
| Jun 30, 2025 | 311.00 Mn |
| Mar 31, 2025 | -193.00 Mn |
| Dec 31, 2024 | 488.00 Mn |
| Sep 30, 2024 | 253.00 Mn |
| Jun 30, 2024 | 115.00 Mn |
| Mar 31, 2024 | 163.00 Mn |
| Dec 31, 2023 | 531.00 Mn |
| Sep 30, 2023 | 365.00 Mn |
| Jun 30, 2023 | 351.00 Mn |
| Mar 31, 2023 | 479.00 Mn |
| Dec 31, 2022 | 439.00 Mn |
| Sep 30, 2022 | 290.00 Mn |
| Jun 30, 2022 | 274.00 Mn |
| Mar 31, 2022 | 208.00 Mn |
| Dec 31, 2021 | 693.00 Mn |
| Sep 30, 2021 | 675.00 Mn |